Načítá se...
CTLA4Ig inhibits effector T cells through regulatory T cells and TGFβ()
The CD28 costimulatory receptor is a critical regulator of T cell function making it an attractive therapeutic target for the treatment of immune mediated diseases. CTLA4Ig, now approved for use in humans, prevents naive T cell activation by binding to B7-proteins and blocking engagement of CD28. Ho...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3775269/ https://ncbi.nlm.nih.gov/pubmed/23956428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1300830 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|